Characterisation of estrogenic 17β-hydroxysteroid dehydrogenase (17β-HSD) activity in the human brain

Journal of Steroid Biochemistry and Molecular Biology

Volumn 86, Issue 1, 2003, Pages 79-92

  Steckelbroeck, Stephan ^a,b   Watzka, Matthias ^c   Reissinger, Annette ^a,b   Wegener Toper, Petra ^b   Bidlingmaier, Frank ^b   Bliesener, Niklaas ^b   Hans, Volkmar H J ^b   Clusmann, Hans ^b   Ludwig, Michael ^b   Siekmann, Lothar ^b   Klingmüller, Dietrich ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c Institute of Transfusion Medicine and Immune Haematology   (Germany)

Author keywords

17 Ketosteroid reductase; 17 Hydroxysteroid oxidase; Central nervous system

Indexed keywords

17 OXOSTEROID; ANDROSTENEDIOL; ANDROSTENEDIONE; ESTRADIOL; ESTRONE; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; PRASTERONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA;

ALLOSTERISM; ARTICLE; CATALYSIS; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICHAELIS MENTEN KINETICS; NEOCORTEX; OXIDATION; REDUCTION; TEMPORAL LOBE; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; WHITE MATTER; ADOLESCENT; ADULT; BIOSYNTHESIS; BRAIN; CELL FRACTIONATION; CHILD; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; KINETICS; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PH; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

17-HYDROXYSTEROID DEHYDROGENASES; ADOLESCENT; ADULT; ANDROSTENEDIOL; BRAIN; CHILD; CHILD, PRESCHOOL; DEHYDROEPIANDROSTERONE; ESTRADIOL; ESTRONE; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOENZYMES; KINETICS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; SUBSTRATE SPECIFICITY; TEMPORAL LOBE; TESTOSTERONE;

EID: 0042928062     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00251-6     Document Type: Article

References (57)

1. McEwen B.S. Steroid hormones are multifunctional messengers to the brain. Trends Endocrinol. Metab. 2:1991;62-67.
2. MacLusky N.J., Naftolin F. Sexual differentiation of the central nervous system. Science. 211:1981;1294-1303.
3. Balthazart J., Ball G.F. Sexual differentiation of brain and behavior in birds. Trends Endocrinol. Metab. 6:1995;21-29.
4. Joëls M. Steroid hormones and excitability in the mammalian brain. Front. Neuroendocrinol. 18:1997;2-48.
5. Rupprecht R., Holsboer F. Neuroactive steroids: mechanism of action and neuropsychopharmacological perspectives. Trends Neurosci. 22:1999;410-416.
6. Berman K.F., Schmidt P.J., Rubinow D.R., Danaceau M.A., van Horn J.D., Esposito G., Ostrem J.L., Weinberger D.R. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8836-8841.
7. McEwen B.S., Alves S.E., Bulloch K., Weiland N.G. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 48:1997;S8-S15.
8. Wickelgren I. Estrogen stakes claim to cognition. Science. 276:1997;675-678.
9. Sherwin B.B. Estrogen effects on cognition in menopausal women. Neurology. 48:1997;S21-S26.
10. Naftolin F., Leranth C., Perez J., Garcia-Segura L.M. Estrogen induces synaptic plasticity in adult primate neurons. Neuroendocrinology. 57:1993;935-939.
11. Foy M.R. 17β-Estradiol: effect on CA1 hippocampal synaptic plasticity. Neurobiol. Learn. Memb. 76:2001;239-252.
12. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63:2001;29-60.
13. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Böttner M., Rosewell K.L. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Rev. 37:2001;313-319.
14. Green P.S., Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Devl. Neurosci. 18:2000;347-358.
15. Birge S.J. The role of estrogen in the treatment of Alzheimers's disease. Neurology. 48:1997;S36-S41.
16. Cyr M., Calon F., Morissette M., di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J. Psychiatry Neurosci. 27:2002;12-27.
17. Morrell M.J. Hormones and epilepsy through the lifetime. Epilepsia. 33:1992;S49-S61.
18. Silva I., Mor G., Naftolin F. Estrogen and the aging brain. Maturitas. 38:2001;95-101.
19. Ciocca D.R., Vargas Roig L.M. Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocr. Rev. 16:1995;35-62.
20. Rissman E.F., Heck A.L., Leonard J.E., Shupnik M.A., Gustafsson J.A. Disruption of estrogen receptor β gene impairs spatial learning in female mice. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3996-4001.
21. Mueller S.O., Korach K.S. Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr. Opin. Pharmacol. 1:2001;613-619.
22. Gu Q., Moss R.L. Novel mechanism for non-genomic action of 17β-oestradiol on kainate-induced currents in isolated rat CA1 hippocampal neurones. J. Physiol. Lond. 506:1998;605-612.
23. Ramirez V.D., Zheng J. Membrane sex-steroid receptors in the brain. Front. Neuroendocrinol. 17:1996;402-439.
24. Labrie F., Luu-The V., Lin S.X., Labrie C., Simard J., Labrie C., El-Alfy M., Pelletier G., Bélanger A. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J. Mol. Endocrinol. 25:2000;1-16.
25. Labrie F., Poulin R., Simard J., Zhao H.F., Labrie C., Dauvois S., Dumont M., Hatton A.C., Poirier D., Merand Y. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Ann. N.Y. Acad. Sci. 595:1990;130-148.
26. Adamski J., Jakob F.J. A guide to 17β-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 171:2001;1-4.
27. Luu-The V. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase. J. Steroid. Biochem. Mol. Biol. 76:2001;143-151.
28. Peltoketo H., Luu-The V., Simard J., Adamski J. 17β-Hydroxysteroid dehydrogenase (HSD)/17ketosteroid reductase (KSR) family nomenclature and main characteristics of the 17HSD/KSR enzymes. J. Mol. Endocrinol. 23:1999;1-11.
29. Luu-The V., Zhang Y., Poirier D., Labrie F. Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. J. Steroid. Biochem. Mol. Biol. 55:1995;581-587.
30. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Schramm J., Bidlingmaier F., Klingmüller D. Expression of 17β-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J. Endocrinol. 160:1999;119-126.
31. Steckelbroeck S., Stoffel-Wagner B., Reichelt R., Schramm J., Bidlingmaier F., Siekmann L., Klingmüller D. Characterization of 17β-hydroxysteroid dehydrogenase activity in the human brain: testosterone formation in the human temporal lobe. J. Neuroendocrinol. 6:1999;457-464.
32. Lowry O.H., Rosebrough N.J., Farr L.A., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
33. Lin H.K., Jez J.M., Schlegel B.P., Peehl D.M., Pachter J.A., Penning T.M. Expression and characterization of recombinant type 2 3α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3α/17β-HSD activity and cellular distribution. Mol. Endocrinol. 11:1997;1971-1984.
34. Steckelbroeck S., Watzka M., Stoffel-Wagner B., Hans V.H.J., Redel L., Clusmann H., Elger C.E., Bidlingmaier F., Klingmüller D. Expression of 17β-hydroxysteroid dehydrogenase type 5 mRNA in the human temporal lobe. Mol. Cell. Endocrinol. 171:2001;165-168.
35. Dufort I., Rheault P., Huang X.F., Soucy P., Luu-The V. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology. 140:1999;568-574.
36. Penning T.M., Burczynski M.E., Jez J.M., Lin H.K., Ma H., Moore M., Ratnam K., Palackal N. Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3). Mol. Cell. Endocrinol. 171:2001;137-149.
37. Pittaway D.E., Andersen R.N., Givens J.R. Deficient 17β-hydroxysteroid oxidoreductase activity in testis from a male pseudohermaphrodite. J. Clin. Endocrinol. Metab. 43:1976;457-461.
38. Geissler W.M., Davis D.L., Wu L., Bradshaw K.D., Patel S., Mendonca B.B., Elliston K.O., Wilson J.D., Russell D.W., Andersson S. Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat. Genet. 7:1994;34-39.
39. Oshima H., Ochiai K. On testicular 17β-hydroxysteroid oxidoreductase product activation of testosterone formation from androstenedione in vitro. Biochim. Biophys. Acta. 306:1973;227-236.
40. de Launoit Y., Adamski J. Unique multifunctional HSD17B4 gene product: 17β-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J. Mol. Endocrinol. 22:1999;227-240.
41. Adamski J., Normand T., Leenders F., Monté D., Begue A., Stéhelin D., Jungblut P.W., de Launoit Y. Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV. Biochem. J. 311:1995;437-443.
42. Carstensen J.F., Tesdorpf J.G., Kaufmann M., Markus M.M., Husen B., Leenders F., Jakob F., de Launoit Y., Adamski J. Characterization of 17β-hydroxysteroid dehydrogenase IV. J. Endocrinol. 150:1996;S21-S30.
43. Duan W.R., Linzer D.I., Gibori G. Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor. J. Biol. Chem. 271:1996;15602-15607.
44. Krazeisen A., Breitling R., Imai K., Fritz S., Möller G., Adamski J. Determination of cDNA gene structure and chromosomal localization of the novel human 17β-hydroxysteroid dehydrogenase type 7. FEBS Lett. 460:1999;373-379.
45. Peltoketo H., Nokelainen P., Piao Y.S., Vihko R., Vihko P. Two 17β-hydroxysteroid dehydrogenases (17HSDs) of estradiol biosynthesis: 17HSD type 1 and type 7. J. Steroid. Biochem. Mol. Biol. 69:1999;431-439.
46. Ando A., Kikuti Y.Y., Shigenari A., Kawata H., Okamoto N., Shiina T., Chen L., Ikemura T., Abe K., Kimura M., Inoko H. cDNA cloning of the human homologues of the mouse Ke4 and Ke6 genes at the centromeric end of the human MHC region. Genomics. 35:1996;600-602.
47. Fomitcheva J., Baker M.E., Anderson E., Lee G.Y., Aziz N. Characterization of Ke 6, a new 17β-hydroxysteroid dehydrogenase, and its expression in gonadal tissues. J. Biol. Chem. 273:1998;22664-22671.
48. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., Stern D. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 389:1997;689-695.
49. He X.Y., Schulz H., Yang S.Y. A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid β-peptide-binding protein involved in Alzheimer's disease. J. Biol. Chem. 273:1998;10741-10746.
50. He X.Y., Merz G., Mehta P., Schulz H., Yang S.Y. Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17β-hydroxysteroid dehydrogenase. J. Biol. Chem. 274:1999;15014-15029.
51. X.Y. He, G. Merz, P.Y.Z. Yang, P. Mehta, H. Schulz, S.Y. Yang, Characterization and localization of human type 10 17β-hydroxysteroid dehydrogenase, Eur. J. Biochem. 268 (2001) 4899-4907.
52. Brereton P., Suzuki T., Sasano H., Li K., Duarte C., Obeyesekere V., Komesaroff P., Krozowski Z. Pan 1b (17β-HSD 11): enzymatic activity and distribution in the lung. Mol. Cell. Endocrinol. 171:2001;111-117.
53. Li K.X., Smith R.E., Krozowski Z.S. Cloning and expression of a novel tissue specific 17β-hydroxysteroid dehydrogenase. Endocr. Res. 24:1998;663-667.
54. Haeseleer F., Palczewski K. Short-chain dehydrogenases/reductases in retina. Methods Enzymol. 316:2000;372-383.
55. Jörnvall H., Persson B., Krook M., Atrian S., Gonzàlez-Duarte R., Jeffery J., Ghosh D. Short-chain dehydrogenases/reductases (SDR). Biochemistry. 34:1995;6003-6013.
56. Jez J.M., Bennett M.J., Schlegel B.P., Lewis M., Penning T.M. Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 326:1997;625-636.
57. Green P.S., Gordon K., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 63:1997;229-235.